Clinical trial demonstrates the impact of therapeutic plasma exchange on biological age

A first-of-its-kind clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous immunoglobulin reduced biological age on average by 2.6 years, as measured by multi-omic biomarkers. Results of the single-blind, placebo-controlled trial are published in Aging Cell.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup